HLVX
Price
$1.89
Change
-$0.03 (-1.57%)
Updated
May 9, 02:07 PM (EDT)
Capitalization
95.77M
90 days until earnings call
SCPH
Price
$2.51
Change
+$0.10 (+4.15%)
Updated
May 8 closing price
Capitalization
121.18M
11 days until earnings call
Ad is loading...

HLVX vs SCPH

Header iconHLVX vs SCPH Comparison
Open Charts HLVX vs SCPHBanner chart's image
HilleVax
Price$1.89
Change-$0.03 (-1.57%)
Volume$900
Capitalization95.77M
scPharmaceuticals
Price$2.51
Change+$0.10 (+4.15%)
Volume$106.95K
Capitalization121.18M
HLVX vs SCPH Comparison Chart
Loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLVX vs. SCPH commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLVX is a Hold and SCPH is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (HLVX: $1.91 vs. SCPH: $2.51)
Brand notoriety: HLVX and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLVX: 110% vs. SCPH: 22%
Market capitalization -- HLVX: $95.77M vs. SCPH: $121.18M
HLVX [@Biotechnology] is valued at $95.77M. SCPH’s [@Biotechnology] market capitalization is $121.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLVX’s FA Score shows that 1 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • HLVX’s FA Score: 1 green, 4 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, HLVX is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLVX’s TA Score shows that 6 TA indicator(s) are bullish while SCPH’s TA Score has 5 bullish TA indicator(s).

  • HLVX’s TA Score: 6 bullish, 3 bearish.
  • SCPH’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than SCPH.

Price Growth

HLVX (@Biotechnology) experienced а -1.04% price change this week, while SCPH (@Biotechnology) price change was -0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.12%. For the same industry, the average monthly price growth was +11.05%, and the average quarterly price growth was -13.39%.

Reported Earning Dates

HLVX is expected to report earnings on Aug 07, 2025.

SCPH is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-5.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPH($121M) has a higher market cap than HLVX($95.8M). HLVX YTD gains are higher at: -7.729 vs. SCPH (-29.096). SCPH has higher annual earnings (EBITDA): -71.31M vs. HLVX (-143.17M). HLVX has more cash in the bank: 189M vs. SCPH (91.5M). HLVX has less debt than SCPH: HLVX (25M) vs SCPH (52.5M). SCPH has higher revenues than HLVX: SCPH (30.3M) vs HLVX (0).
HLVXSCPHHLVX / SCPH
Capitalization95.8M121M79%
EBITDA-143.17M-71.31M201%
Gain YTD-7.729-29.09627%
P/E RatioN/AN/A-
Revenue030.3M-
Total Cash189M91.5M207%
Total Debt25M52.5M48%
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HLVXSCPH
RSI
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSOPX15.94N/A
N/A
North Star Opportunity A
FSNIX15.64N/A
N/A
Fidelity Advisor Asset Manager 60% I
IOVFX15.88N/A
N/A
GMO International Opportunistic Val I
RAPRX10.68-0.05
-0.47%
Cohen & Steers Real Assets R
GSVRF0.12N/A
-2.48%
GUANAJUATO SILVER CO LTD

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
+3.24%
FBIOP - HLVX
83%
Closely correlated
-6.18%
BRIBF - HLVX
55%
Loosely correlated
N/A
PLRX - HLVX
37%
Loosely correlated
N/A
NTLA - HLVX
37%
Loosely correlated
+13.58%
SCPH - HLVX
33%
Loosely correlated
+4.15%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with BEAM. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+4.15%
BEAM - SCPH
44%
Loosely correlated
+6.32%
XERS - SCPH
43%
Loosely correlated
+15.18%
CRSP - SCPH
43%
Loosely correlated
+5.52%
IMNM - SCPH
43%
Loosely correlated
+3.77%
ABCL - SCPH
42%
Loosely correlated
N/A
More